Hologic Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States and internationally. The company operates in four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company was founded in 1985 and is based in Bedford, Massachusetts.
HOLX Price Forecast Based on DCF Valuation
DCF Fair Value Target:
The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Hologic Inc. To summarize, we found that Hologic Inc ranked in the 28th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. As for the metrics that stood out in our discounted cash flow analysis of Hologic Inc, consider:
Hologic Inc's effective tax rate, as measured by taxes paid relative to net income, is at 0 -- greater than merely 0% of US stocks with positive free cash flow.
The weighted average cost of capital for the company is 7. This value is greater than just 21.45% stocks in the Healthcare sector that generate free cash flow.
Terminal Growth Rate in Free Cash Flow
Return Relative to Current Share Price
ABT, ESMC, BHC, CNMD, and IONS can be thought of as valuation peers to HOLX, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.
Calgary, Alberta--(Newsfile Corp. - June 30, 2020) - Braveheart Resources Inc. (TSXV: BHT) (OTCQB: RIINF) ("Braveheart" or, the "Company") hereby announces the engagement of GRA Enterprises LLC for the provision of investor relations services pursuant to a consulting agreement dated June 5, 2020. Services include the production and publication of investor relations bulletins, distribution of investor bulletins to the consultant's e-mail list, and posts through the consultant's blogs and social media accounts. ...